Rooted in Huangpu, committed to CIIE: a nine-time exhibitor writes the next chapter in cellular health

Rooted in Huangpu, committed to CIIE: a nine-time exhibitor writes the next chapter in cellular health

Summary

New Zealand cellular health brand MitoQ, a nine-time exhibitor at the China International Import Expo (CIIE), showcased its products in the medical equipment and healthcare section at CIIE 2026 and announced it will base its China office in Huangpu, Shanghai. MitoQ chief executive Mahara Inglis said Huangpu is Shanghai's centre of growth, innovation and talent, and that support from local government during the establishment process had given the team confidence. He recalled that nine years ago the brand started with a single product, a small booth and a handful of staff, and has since grown exponentially with a large booth, with CIIE remaining the most important window for the brand to connect with partners and reach domestic consumers.

At this year's expo, MitoQ gave an Asian debut to three products in its cell essentials range — marine fucoxanthin capsules, equol women's balance capsules and triple magnesium complex capsules — rounding out its everyday base nutrition portfolio in step with the Healthy China 2030 direction. The brand also signed a strategic healthy ageing cooperation agreement with Yiling Medical Technology Group, under which MitoQ provides brand, talent and patented technology while the partner contributes clinical resources, hospitals and research capability, with the two sides to explore a closed-loop personalised health service at the cellular level. The recognition of MitoQ® Mitoquinol by Australia's TGA further strengthens the brand's international professional foundation.

Commentary

MitoQ, a representative New Zealand brand in cellular health, has exhibited at CIIE for nine consecutive years and established itself in Huangpu, Shanghai, reflecting the structural opportunities in China's health market. China's dietary supplement market is growing at about 10 percent a year, with segments such as cellular anti-ageing and women's health expanding particularly fast, though competition is intensifying and Australian brands such as Swisse and Blackmores have already established first-mover advantages. MitoQ's launch of the cell essentials range and its partnership with Yiling Medical are aimed at extending from a single premium product into base nutrition and personalised services, offering a path for small and medium-sized New Zealand health companies: use the CIIE platform to build channel awareness quickly while working with local medical resources to lower market-entry barriers.

However, China's registration and filing requirements for imported health foods are strict and consumers are increasingly cautious about efficacy claims, so New Zealand companies need to keep investing in scientific backing and local compliance. For New Zealand SME owners, the MitoQ case shows that the opportunity in China lies not only in product exports but also in deeper alignment of service models and R&D collaboration.

Keywords: MitoQ, CIIE, cellular health, Huangpu, Mahara Inglis, healthy ageing, Asian debut, Yiling Medical Technology Group


Photo by TheDigitalArtist on Pixabay

Source: eastday.com

Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.

Leave a Reply

Your email address will not be published. Required fields are marked *